England - London • Industry focus
Fieldfisher
With a ‘stellar reputation’ among clients for its regulatory capabilities, the team at Fieldfisher assists clients with a myriad of issues, including the funding and development of biotech programmes, and the commercialisation of products. The ‘exceptionally talented and knowledgeable’ Janita Good leads the team, handling a broad range of transactional matters, including co-operative research, structured licensing, and equity investment issues. Sarah Ellson leads the regulatory team, often advising medical manufacturers and pharmaceutical companies on patient support programmes and clinical trials. Cliodhna McDonough-Stevens has since left the team to work in-house.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Fieldfisher have developed a stellar reputation for their regulatory practice across life sciences and healthcare.’
'Janita Good and her team are always helpful and very switched on.’
‘Janita Good is an exceptionally talented and knowledgeable life sciences solicitor. Her advice is often very creative, but pragmatic and to the point. I value her advice highly and her people skills, especially in difficult negotiations, are very good. I am very happy to recommend Janita to colleagues and friends in the sector.’
Key clients
- Roche Products Limited
- Fresenius Kabi
- BAGI Group Limited
- EB Research Partnership EBRB
- Synairgen plc
- Inspiration Healthcare plc
- Syneos Health UK
- Ultromics
- InnovaDerma
- LetterOne
- Human Tissue Authority
- NHS Resolution
- Phoenix Healthcare
- General Medical Council
- Sinclair Pharma
Work highlights
- Advised BAGI Group Limited on an equity investment lead by funds managed by a leading Hong Kong group together with a patent co-ownership and development agreement with an institution in Hong Kong, which could enable a range of new products based on botanical drugs.
- Advised Roche Products Limited on novel routes to authorisation of treatments that turned out to be effective against the Covid-19 virus, and new data-sharing agreements with the NHS.
- Advised EB Research Partnership EBRB on equity investment into Mariposa Limited using an innovative model of funding to deploy charitable funds into rare disease research through equity investment.
Lawyers
Next Generation Partners
Practice head
The lawyer(s) leading their teams.
Janita Good